X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Dr. Reddys with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

DR. REDDYS LAB    Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-18
ADCOCK INGRAM
Jun-14
DR. REDDYS LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,788345-   
Low Rs1,902249-   
Sales per share (Unadj.) Rs860.8102.7-  
Earnings per share (Unadj.) Rs57.1-25.9-  
Cash flow per share (Unadj.) Rs122.0-21.4-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs757.780.6-  
Shares outstanding (eoy) m165.91168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.72.9 94.2%   
Avg P/E ratio x41.1-11.5 -357.8%  
P/CF ratio (eoy) x19.2-13.9 -138.7%  
Price / Book Value ratio x3.13.7 83.9%  
Dividend payout %35.00-   
Avg Mkt Cap Rs m389,03450,132 776.0%   
No. of employees `00023.54.3 548.0%   
Total wages/salary Rs m32,1493,146 1,021.8%   
Avg. sales/employee Rs Th6,070.84,036.0 150.4%   
Avg. wages/employee Rs Th1,366.6732.9 186.5%   
Avg. net profit/employee Rs Th402.5-1,017.0 -39.6%   
INCOME DATA
Net Sales Rs m142,81017,326 824.2%  
Other income Rs m1,552121 1,279.1%   
Total revenues Rs m144,36217,448 827.4%   
Gross profit Rs m23,512-3,003 -783.1%  
Depreciation Rs m10,772748 1,440.5%   
Interest Rs m788469 167.9%   
Profit before tax Rs m13,504-4,098 -329.5%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m3440-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,380256 1,710.3%   
Profit after tax Rs m9,468-4,366 -216.9%  
Gross profit margin %16.5-17.3 -95.0%  
Effective tax rate %32.4-6.2 -519.1%   
Net profit margin %6.6-25.2 -26.3%  
BALANCE SHEET DATA
Current assets Rs m104,98412,690 827.3%   
Current liabilities Rs m68,9387,140 965.5%   
Net working cap to sales %25.232.0 78.8%  
Current ratio x1.51.8 85.7%  
Inventory Days Days74111 67.0%  
Debtors Days Days104124 83.6%  
Net fixed assets Rs m104,3857,397 1,411.2%   
Share capital Rs m83080 1,031.8%   
"Free" reserves Rs m124,8860-   
Net worth Rs m125,71613,599 924.4%   
Long term debt Rs m25,0894,779 525.0%   
Total assets Rs m225,44325,690 877.5%  
Interest coverage x18.1-7.7 -234.6%   
Debt to equity ratio x0.20.4 56.8%  
Sales to assets ratio x0.60.7 93.9%   
Return on assets %4.5-15.2 -30.0%  
Return on equity %7.5-32.1 -23.5%  
Return on capital %9.7-19.8 -49.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m53,7070-   
CASH FLOW
From Operations Rs m18,0301,479 1,219.1%  
From Investments Rs m-14,883-454 3,277.4%  
From Financial Activity Rs m-4,4404,337 -102.4%  
Net Cashflow Rs m-1,2365,362 -23.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.76 Rs / ZAR

Compare DR. REDDYS LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: DISHMAN PHARMA  ALKEM LABORATORIES  TTK HEALTHCARE  BIOCON   GLENMARK PHARMA  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views On News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

This is Why You Need to Buy Small Cap Stocks Now(The 5 Minute Wrapup)

Mar 15, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Mar 20, 2019 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS